Cargando…

An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases

The CSF-470 vaccine (VACCIMEL) plus BCG and GM-CSF as adjuvants has been assayed in cutaneous melanoma patients. In the adjuvant randomized Phase II study CASVAC-0401, vaccinated patients had longer distant metastasis-free survival (DMFS) than those treated with IFNα2b. Five years after locking the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mordoh, Ana, Aris, Mariana, Carri, Ibel, Bravo, Alicia Inés, Podaza, Enrique, Pardo, Juan Carlos Triviño, Cueto, Gerardo Rubén, Barrio, María Marcela, Mordoh, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011367/ https://www.ncbi.nlm.nih.gov/pubmed/35432383 http://dx.doi.org/10.3389/fimmu.2022.842555

Ejemplares similares

Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report
por: Mordoh, Ana, et al.
Publicado: (2023)

Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF
por: Podaza, Enrique, et al.
Publicado: (2020)

Inoculation Site from a Cutaneous Melanoma Patient Treated with an Allogeneic Therapeutic Vaccine: A Case Report
por: Aris, Mariana, et al.
Publicado: (2015)

Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood
por: Aris, Mariana, et al.
Publicado: (2019)

Lessons from Cancer Immunoediting in Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2012)

Immunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2017)

Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report
por: Aris, Mariana, et al.
Publicado: (2018)

HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy
por: Bravo, Alicia Inés, et al.
Publicado: (2023)

Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants
por: Pampena, María B., et al.
Publicado: (2018)

A word of caution: do not wake sleeping dogs; micrometastases of melanoma suddenly grew after progesterone treatment
por: Mordoh, Jose, et al.
Publicado: (2013)

Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release
por: Pampena, María B., et al.
Publicado: (2017)

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study
por: Mordoh, José, et al.
Publicado: (2017)

Melanoma Vaccines and Modulation of the Immune System in the Clinical Setting: Building from New Realities
por: Madorsky-Rowdo, Florencia Paula, et al.
Publicado: (2012)

Cerebral metastases of cutaneous melanoma.
por: Gupta, G., et al.
Publicado: (1997)

MALIGNANT MELANOMA – CUTANEOUS METASTASES
por: Padmavathy, L, et al.
Publicado: (2008)

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression
por: von Euw, Erika M, et al.
Publicado: (2008)

Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long-term BRAF inhibition
por: Rowdo, Florencia Paula Madorsky, et al.
Publicado: (2020)

Editorial: “Cancer Immunotherapy: Lights and Shadows”
por: Barrio, María Marcela, et al.
Publicado: (2015)

Multiple cutaneous metastases of amelanotic melanoma
por: Grupioni, Priscila Vinhal, et al.
Publicado: (2018)

Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases
por: In, Gino K., et al.
Publicado: (2020)

Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model
por: Keon, Soledad Mac, et al.
Publicado: (2019)

Human Macrophages and Dendritic Cells Can Equally Present MART-1 Antigen to CD8(+) T Cells after Phagocytosis of Gamma-Irradiated Melanoma Cells
por: Barrio, María Marcela, et al.
Publicado: (2012)

The Diagnosis and Management of Cutaneous Metastases from Melanoma
por: Di Raimondo, Cosimo, et al.
Publicado: (2023)

In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells
por: Rowdo, Florencia Paula Madorsky, et al.
Publicado: (2017)

Systemic adjuvant therapy for high-risk cutaneous melanoma
por: Kobeissi, Iyad, et al.
Publicado: (2022)

Multiple cutaneous melanomas associated with gastric and brain metastases
por: Grander, Lara Caroline, et al.
Publicado: (2016)

Comprehensive analysis of cutaneous and uveal melanoma liver metastases
por: Hoefsmit, Esmee P, et al.
Publicado: (2020)

Combining Immunotherapy with Oncogene-Targeted Therapy: A New Road for Melanoma Treatment
por: Aris, Mariana, et al.
Publicado: (2015)

Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
por: Kraehn, G M, et al.
Publicado: (2001)

Celecoxib as a Valuable Adjuvant in Cutaneous Melanoma Treated with Trametinib
por: Tudor, Diana Valentina, et al.
Publicado: (2021)

Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+ )T lymphocytes
por: von Euw, Erika M, et al.
Publicado: (2007)

Determinants of survival in patients with brain metastases from cutaneous melanoma
por: Staudt, M, et al.
Publicado: (2010)

Popliteal lymph node dissection for metastases of cutaneous malignant melanoma
por: Teixeira, Frederico, et al.
Publicado: (2014)

Bilateral Choroidal Metastases as Presentation of Dissemination of Cutaneous Malignant Melanoma
por: Fernandez-Perez, S., et al.
Publicado: (2012)

Amelanotic metastatic cutaneous melanoma
por: Mendes, Marcela Sena Teixeira, et al.
Publicado: (2013)

Cutaneous melanoma
por: Négrier, S, et al.
Publicado: (2001)

Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting
por: Lipson, Evan J, et al.
Publicado: (2015)

Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases
por: Yeh, Jennifer E., et al.
Publicado: (2022)

Adjuvant Therapy: Melanoma
por: Davar, Diwakar, et al.
Publicado: (2011)

Adjuvant Treatment of Melanoma
por: Moreno Nogueira, J. A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_964ifu8omcbsge2a4d1v6g13fo